Journal articleCancers (Basel)2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.
- Journal
- Cancers (Basel)
- Published
- 4 May 2023
- Citations
- 8
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Grants 5
- Core C-Computational Core P01CA117969↗
- Administrative Core P50CA221707↗
- Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation R01CA195651↗
- Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis R01CA196941↗
- Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas U01CA196403↗